Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
about
Lipid peroxidation: pathophysiological and pharmacological implications in the eyeThe management of glaucoma and intraocular hypertension: current approaches and recent advancesNeuroprotection in GlaucomaEndogenous and Synthetic Cannabinoids as Therapeutics in Retinal DiseaseRetinal Cell Degeneration in Animal ModelsCurrent perspective of neuroprotection and glaucomaCellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion InjurySubtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve headColour Doppler imaging and fluorescein filling defects of the optic disc in normal tension glaucoma.Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma.Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cellsCalpain activation in experimental glaucoma.Gene transcription profile of the detached retina (An AOS Thesis).Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patientsNeuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage.Novel neuroprotective strategies in ischemic retinal lesions.Evaluation of hemodynamic parameters as predictors of glaucoma progressionRapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma.Plasminogen activators promote excitotoxicity-induced retinal damageIntravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9.Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats.5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies.In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina.Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.Simultaneous management of blood flow and IOP in glaucoma.A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucomaLiposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury.Pharmacodynamics of citicoline relevant to the treatment of glaucoma.Immunochemical changes of calbindin, calretinin and SMI32 in ischemic retinas induced by increase of intraocular pressure and by middle cerebral artery occlusion.Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance.Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retinaVisual improvement following glaucoma surgery: a case report.Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death.Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the neurodegeneration process in the pathogenesis of primary open angle glaucoma.Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow.Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.Optic nerve and neuroprotection strategies.Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.
P2860
Q21129236-E9C87242-C041-4AE0-800A-131D627DED25Q22305849-A5F19FBF-7786-421D-9360-295EE9335965Q26740388-C09AED7A-56F0-4FC1-AB04-710D4F74700CQ26765576-ACB949BA-8A19-430D-AF17-48FB044DD6E6Q26771160-3FD07EF2-AA6D-40F9-8648-482A8463346AQ26774852-2BACC1BF-08CD-47DB-B149-57EE1574F147Q28079203-EBF01D86-A36E-4C69-972D-3988A8E6A569Q28240099-DD22E181-450F-4706-97A7-1D3143CC0EE4Q31143645-8D8E856E-F07D-4C99-966A-38108FF04214Q33210294-9AA6942C-C25D-431C-9826-576DEEED655BQ33308961-E42A345B-9C4E-4357-9AA3-F20685A54865Q33526954-9DCD88E6-0C00-4913-8559-C42211F4ED82Q33623534-3EE612DF-B0B0-4F69-B4DE-DEF11600042FQ33642786-05F455B1-B710-4A7A-8B44-0B14EDE5B271Q33711010-66C49404-A63D-46BF-93E4-6F19155B92AEQ33763124-1043A9BD-11CA-48A2-8630-7C9DF75A3D53Q33782169-677AA2CF-7594-46CE-9B80-997D035BBCD4Q33902190-630ACA9D-9F1B-4663-BB8F-78937D2C6F5EQ33926990-349119D3-EFD3-4B89-8B45-701F1F761D65Q33946252-11EF3E74-1EE2-42B4-986E-388E1BC5B55BQ33947249-E5CB2E07-0345-443A-AA2C-2E8144F82376Q34032301-46BF47B0-B8A5-4A9B-A5D3-1101DF199295Q34057619-36132B05-BD46-4FF2-9ABA-64AD70585B4BQ34057625-EC41F3D5-4D7C-4567-BD12-37CA5455C6DDQ34109774-1BE2412A-0B61-4227-AAF7-7D9187B8C67AQ34208396-E49057CB-5C2E-4BF3-B553-E0745E332E58Q34308798-39305A24-6C3D-438E-945A-AB96F2ECFEEAQ34377317-1F28EA2B-9674-4C89-BC39-3E7C60BB5B7BQ34452897-32FF60D5-60DE-4CE0-AB1E-4045AD2B7FF8Q34488157-08BB9655-0579-4D9A-8113-9BD4F7876D80Q34822161-F2D6BAE1-4C37-4FB4-90D3-B7A3F87D3619Q34928181-2F2FD4A7-E085-4521-8691-335B319F2484Q34936856-F1F3F217-4168-4833-992F-D13B32C624F5Q34937551-ECD7E9F9-B4F0-439C-BF81-A45FF5B22937Q35097109-FFF56261-CB54-4FCC-B526-CDF60B0D55C0Q35373186-97BCD9E2-23C9-49C3-AE4C-4059E21FA651Q35590459-65BE21E8-AF74-4484-958E-511A82051BEDQ35677091-E8379BB1-D858-4E28-A945-1726901D506AQ35944015-936CA8BA-7B06-4846-9231-1E989A1C30A4Q36048575-C7AD94F1-E5B5-4A01-A436-662AF8EE248F
P2860
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@ast
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@en
type
label
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@ast
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@en
prefLabel
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@ast
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@en
P2093
P1476
Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
@en
P2093
Osborne NN
P304
P356
10.1016/S0039-6257(99)00044-2
P478
43 Suppl 1
P577
1999-06-01T00:00:00Z